EPHA2 and melanoma: Finally, activation of RTK may be also driven by induction of the EPHA2 signaling; in melanoma cells resistant to vemurafenib, EPHA2 overexpression seems to contribute to cell survival and viability as well as to promotion of metastasis formation (84, 85).